학술논문
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
Document Type
Journal Article
Author
Ramacciotti, Eduardo; Barile Agati, Leandro; Calderaro, Daniela; Aguiar, Valéria Cristina Resende; Spyropoulos, Alex C; de Oliveira, Caroline Candida Carvalho; Lins dos Santos, Jessica; Volpiani, Giuliano Giova; Sobreira, Marcone Lima; Joviliano, Edwaldo Edner; Bohatch Júnior, Milton Sérgio; da Fonseca, Benedito Antônio Lopes; Ribeiro, Maurício Serra; Dusilek, Cesar; Itinose, Kengi; Sanches, Suzanna Maria Viana; de Almeida Araujo Ramos, Karine; de Moraes, Nara Franzin; Tierno, Paulo Fernando Guimarães Morando Marzocchi; de Oliveira, André Luiz Malavasi Longo
Source
Subject
*RIVAROXABAN
*ANTICOAGULANTS
*INTENSIVE care patients
*THROMBOEMBOLISM
*
*
*
Language
ISSN
0140-6736
Abstract